Skip to main content

Table 1 Details of GWAS summary data and LDSC of single-trait heritability

From: Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis

Traits

Original study (year)

ID

Sample size

Number of cases

Number of controls

Ethnicity

Global h2 (SE)

λGC

MG

Ruth Chia et al. (2022)

GCST90093061

38,243

1,873

36,370

European (U.S., Italy)

0.076 (0.015)

1.059

Early-onset MG

GCST90093465

3,313

595

2,718

European (U.S., Italy)

0.365 (0.135)

1.002

Late-onset

LOMG

GCST90093466

34,930

1,278

33,652

European (U.S., Italy)

0.078 (0.015)

1.044

MG

–

phecode-358.1

324,308

224

324,074

European (U.K.)

0.002 (0.001)

1.011

MG

–

finngen_R10_G6

408,891

461

408,430

European (Finnish)

0.001 (0.001)

1.013

  1. LDSC Linkage disequilibrium score regression, ID GWAS Catalog/UK Biobank/FinnGen ID, Global h2 the estimated SNP-heritability, SE standard error, λGC genomic inflation factor lambda